Blood Flow Mismatch in Pancreatic Cancers Greensboro NC

Finnish researchers say they have identified a blood-flow metabolism mismatch that predicts pancreatic cancer aggressiveness. The investigators used a three-dimensional imaging technique called positron emission tomography (PET) to measure blood flow and glucose consumption -- a measure of general metabolic activity of a tissue -- in 26 people.

James M Granfortuna, MD
(336) 832-1100
501 N Elam Ave
Greensboro, NC
Specialties
Oncology (Cancer)
Gender
Male
Languages
Italian, Spanish
Education
Medical School: Mt Sinai Sch Of Med Of The City Univ Of Ny, New York Ny 10029
Graduation Year: 1980
Hospital
Hospital: Moses H Cone Memorial Hospital, Greensboro, Nc; Wesley Long Community Hospital, Greensboro, Nc; Womens Hospital, Greensboro, Nc
Group Practice: Regional Cancer Center Moses Cone Health System

Data Provided by:
Gustav Charles Magrinat
(336) 832-1100
501 N Elam Ave
Greensboro, NC
Specialty
Internal Medicine, Hematology / Oncology

Data Provided by:
Peter Rubin, MD
(336) 832-1100
501 N Elam Ave
Greensboro, NC
Specialties
Oncology (Cancer), Internal Medicine
Gender
Male
Education
Medical School: Univ Of Calgary, Fac Of Med, Calgary, Alb, Canada
Graduation Year: 1988

Data Provided by:
Matthew A Manning, MD
(336) 832-1100
501 N Elam Ave
Greensboro, NC
Specialties
Oncology (Cancer), Radiation Oncology
Gender
Male
Education
Medical School: Va Commonwealth Univ, Med Coll Of Va Sch Of Med, Richmond Va 23298
Graduation Year: 1996

Data Provided by:
Lennis Pearcy Livesay
(336) 832-1100
501 N Elam Ave
Greensboro, NC
Specialty
Internal Medicine, Medical Oncology

Data Provided by:
Gary Bradley Sherrill, MD
(336) 832-1100
501 N Elam Ave
Greensboro, NC
Specialties
Oncology (Cancer)
Gender
Male
Education
Medical School: Univ Of Nc At Chapel Hill Sch Of Med, Chapel Hill Nc 27599
Graduation Year: 1989

Data Provided by:
Peter Robert Ennever
(336) 832-1100
501 N Elam Ave
Greensboro, NC
Specialty
Hematology, Hematology / Oncology, Medical Oncology

Data Provided by:
Firas N Shadad
(336) 832-1100
501 N Elam Ave
Greensboro, NC
Specialty
Hematology / Oncology

Data Provided by:
Lennis Pearcy Livesay, MD
(336) 832-1100
501 N Elam Ave
Greensboro, NC
Specialties
Oncology (Cancer)
Gender
Female
Education
Medical School: Univ Of Sc Sch Of Med, Columbia Sc 29208
Graduation Year: 1985

Data Provided by:
Dr.Gustav Magrinat
(336) 832-1100
501 North Elam Avenue
Greensboro, NC
Gender
M
Education
Medical School: Univ Of Nc At Chapel Hill Sch Of Med
Year of Graduation: 1987
Speciality
Oncologist
General Information
Accepting New Patients: Yes
RateMD Rating
5.0, out of 5 based on 2, reviews.

Data Provided by:
Data Provided by:

Blood Flow Mismatch in Pancreatic Cancers

Provided By:

WEDNESDAY, Aug. 26 (HealthDay News) -- Finnish researchers say they have identified a blood-flow metabolism mismatch that predicts pancreatic cancer aggressiveness.

The investigators used a three-dimensional imaging technique called positron emission tomography (PET) to measure blood flow and glucose consumption -- a measure of general metabolic activity of a tissue -- in 26 people. The researchers noted that blood flow in malignant tumors was 60 percent less than in normal pancreatic tissue.

The findings may help explain why many pancreatic cancer patients have a poor response to radiation treatment and chemotherapy, the study authors noted in their report published Aug. 25 in Clinical Cancer Research.

"Imaging of several of these tumor parameters might be important for the planning and success of [cancer] therapies," study author Dr. Gaber Komar, research fellow at the Turku PET Center, said in a news release from the American Association for Cancer Research. "We believe that a better understanding of these mechanisms may help overcome the general treatment resistance of pancreatic cancer."

"This study confirms that blood flow metabolism mismatch exists in pancreatic tumors, similar to other cancers such as breast and lung cancers, and predicts poor patient outcome," Dr. David Mankoff, a professor of radiology, medicine and bioengineering at the University of Washington in Seattle, said in the news release.

"A blood flow metabolism mismatch by PET appears to be associated with cancer aggressiveness and treatment resistance. We've only recently recognized this pattern as a result of advantages in functional imaging methods," added Mankoff.

More information

The American Cancer Society has more about pancreatic cancer.

SOURCE: American Association for Cancer Research, news release, Aug. 25, 2009

Copyright © 2009 ScoutNews, LLC. All rights reserved.

Read Article at HealthDay.com